These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 17243603)

  • 1. [The modern view on the use of aspirin for the primary prophylaxis of cardiovascular diseases in women].
    Zakharov OV; Arablinskiĭ AV
    Klin Med (Mosk); 2006; 84(11):10-5. PubMed ID: 17243603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The need for wider and appropriate utilization of aspirin and statins in the treatment and prevention of cardiovascular disease.
    Hennekens CH; Schneider WR
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):95-107. PubMed ID: 18095910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of aspirin treatment in the primary prevention of cardiovascular disease events in subgroups based on age, gender, and varying cardiovascular risk.
    Greving JP; Buskens E; Koffijberg H; Algra A
    Circulation; 2008 Jun; 117(22):2875-83. PubMed ID: 18506010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aspirin in the primary prevention of cardiovascular disease.
    Hennekens CH; Buring JE
    Cardiol Clin; 1994 Aug; 12(3):443-50. PubMed ID: 7805078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aspirin in cardiovascular prevention: does the approach differ by gender?].
    Temizhan A
    Anadolu Kardiyol Derg; 2007 Dec; 7 Suppl 2():2-4. PubMed ID: 18160359
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Women's Health Study: low dose aspirin in primary prevention.
    Murphy SA
    J Am Coll Cardiol; 2005 Sep; 46(5):CS7-8. PubMed ID: 16237869
    [No Abstract]   [Full Text] [Related]  

  • 7. Aspirin chemoprevention recommendations.
    Dressler R
    Fam Pract Manag; 2004 Jun; 11(6):18. PubMed ID: 15227915
    [No Abstract]   [Full Text] [Related]  

  • 8. State of the heart: building science to improve women's cardiovascular health.
    Rosenfeld AG
    Am J Crit Care; 2006 Nov; 15(6):556-66; quiz 567. PubMed ID: 17053263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gender and stroke: acute phase treatment and prevention.
    Sacco S; Cerone D; Carolei A
    Funct Neurol; 2009; 24(1):45-52. PubMed ID: 19403054
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aspirin for primary prevention of cardiovascular disease in women: does sex matter?
    Hung J
    Med J Aust; 2006 Mar; 184(6):260-1. PubMed ID: 16548826
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease prevention tailored for women.
    Engberding N; Wenger NK
    Expert Rev Cardiovasc Ther; 2008 Sep; 6(8):1123-34. PubMed ID: 18793115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aspirin in cardiovascular disease.
    Sexton RC
    Tenn Med; 2001 Jun; 94(6):208-10. PubMed ID: 11402787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Aspirin in primary prevention of cardiovascular diseases: how to balance risks and benefits].
    De Caterina R; Orlando D; Berti V; Coccheri S
    G Ital Cardiol (Rome); 2012; 13(7-8):494-502. PubMed ID: 22781376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aspirin in the primary prevention of cardiovascular disease: current knowledge and future research needs.
    Hennekens CH; Dalen JE
    Trends Cardiovasc Med; 2014 Nov; 24(8):360-6. PubMed ID: 25444455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Primary prevention of cardiovascular disease with acetylsalicylic acid: in high-risk patients].
    Kappelle LJ
    Ned Tijdschr Geneeskd; 2005 Apr; 149(16):853-4. PubMed ID: 15868987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular disease in women: prevention, symptoms, diagnosis, pathogenesis.
    Naderi S; Cho LS
    Cleve Clin J Med; 2013 Sep; 80(9):577-87. PubMed ID: 24001966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experts recommend low-dose aspirin to prevent stroke in women. Lower doses are as effective as higher doses and are likely to be safer.
    Harv Womens Health Watch; 2009 May; 16(9):1. PubMed ID: 19554742
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet inhibitors: what are the data in women?
    Tempelhof MW; Newby LK
    Cardiol Rev; 2008; 16(1):23-9. PubMed ID: 18091399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of sex-specific results reporting in cardiovascular disease.
    Blauwet LA; Redberg RF
    Cardiol Rev; 2007; 15(6):275-8. PubMed ID: 18090061
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treating cardiovascular disease in women.
    Taggu W; Lloyd G
    Menopause Int; 2007 Dec; 13(4):159-64. PubMed ID: 18088527
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.